missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Bortezomib

Click to view available options
Quantity:
5 mg
25 mg
Unit Size:
25mg
5mg
Description
Bortezomib is a high affinity proteasome inhibitor (Ki = 0.6 nM). Inhibits growth of multiple myeloma (MM) cell lines (IC50 values in <50 nM range); induces apoptosis in MM cell lines and MM patient derived cells, including p53 mutant cell lines. Decreases adherence of MM cells lines to bone marrow stromal cells (BMSCs). Acts synergistically with dexamethasone (Cat. No. 1126). Also cytotoxic in MCF-7 breast cancer cell line (IC50 = 50 nM).
Specifications
Specifications
| Chemical Name or Material | B-[(1 R)-3-Methyl-1-[[(2 S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid |
| CAS | 179324-69-7 |
| Quantity | 25 mg |
| Target | Proteasome Inhibitors |
| Molecular Formula | C19H25BN4O4 |
| Purity | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction